Supported by the National Natural Science Foundation of China (No. 30400596), the 211 Project of Jinan University, the Fundamental Research Funds for the Central Universities, Grants from Natural Science Foundation of Jinan University (No. 51204017) and Research Projects of Jinan University Challenge Cup Extracurricular Scientific Activities
Gao, Zm., Yang, L., Huang, F. et al. Effects of different extracts of kanggushu (抗骨疏) on osteoporosis in model rats and the underlying mechanisms., Chin. J. Integr. Med. 19, 844–852 (2013). https://doi.org/10.1007/s11655-012-1190-z
Zhi-ming Gao, Li Yang, Feng Huang, et al. Effects of different extracts of kanggushu (抗骨疏) on osteoporosis in model rats and the underlying mechanisms[J]. Chinese Journal of Integrative Medicine, 2013,19(11):844-852.
Gao, Zm., Yang, L., Huang, F. et al. Effects of different extracts of kanggushu (抗骨疏) on osteoporosis in model rats and the underlying mechanisms., Chin. J. Integr. Med. 19, 844–852 (2013). https://doi.org/10.1007/s11655-012-1190-zDOI:
Zhi-ming Gao, Li Yang, Feng Huang, et al. Effects of different extracts of kanggushu (抗骨疏) on osteoporosis in model rats and the underlying mechanisms[J]. Chinese Journal of Integrative Medicine, 2013,19(11):844-852. DOI: 10.1007/s11655-012-1190-z.
Effects of different extracts of kanggushu (抗骨疏) on osteoporosis in model rats and the underlying mechanisms
摘要
To investigate the preventive effects and possible underlying mechanism of different extracts of Kanggushu (抗骨疏) on osteoporosis in ovariectomized rats. One hundred and sixtyfive female SD rats were divided into 11 groups: control
sham
model
Xianling Gubao Capsule (仙灵骨葆胶囊)
nilestriol
Kanggushu aqueous extract high-
medium-
and low-dose and suet extract high-
medium-
and low-dose groups. The osteoporosis model was made by ovariectomizing the rats. The latter 8 groups were administered intragastricly with Xianling Gubao Capsule
nilestriol
Kanggushu aqueous extract and suet extract for 12 weeks
respectively
while the other 3 groups were administered orally saline. The whole body bone mineral density
bone mineral content
organ coefficient of uterus
serum estradiol and alkaline phosphatase contents
blood calcium
phosphorus
interleukin 6 and bone Gla-protein levels after treatment were monitored. Additionally
three-point bending test of femur
HE staining
and scanning electron microscope were performed to explore the pharmacodynamics and underlying mechanisms. In comparison with ovariectomized rats of model group
Kanggushu aqueous extract high-dose resulted in an increased bone mineral density
bone mineral content and organ coefficient of uterus
improved estradiol level
and improved maximum load and structural stiffness (P<0.05 or P<0.01). Two-dimensional and three-dimensional trabecular structure was also observed under HE staining and scanning electron microscopy
and the number and thickness of trabecular bone in Kanggushu aqueous extract high-dose group was significantly increased compared to the model group
while the lipid droplets in bone marrow cavity were significantly less. However
there were no significant differences in blood calcium
total serum alkaline phosphatase and bone Gla protein among different treatment groups. Overall
the osteoprotective effects of Kanggushu aqueous extract were comparable to those of nilestriol and were significantly more effective than those of Xianling Gubao Capsule. The preventive effects of Kanggushu aqueous extract might be partly due to the increased estradiol level
accelerated restoration of bone trabecular reticulate structure
and accordingly increased bone mineral density in osteoporosis rats.
Abstract
To investigate the preventive effects and possible underlying mechanism of different extracts of Kanggushu (抗骨疏) on osteoporosis in ovariectomized rats. One hundred and sixtyfive female SD rats were divided into 11 groups: control
sham
model
Xianling Gubao Capsule (仙灵骨葆胶囊)
nilestriol
Kanggushu aqueous extract high-
medium-
and low-dose and suet extract high-
medium-
and low-dose groups. The osteoporosis model was made by ovariectomizing the rats. The latter 8 groups were administered intragastricly with Xianling Gubao Capsule
nilestriol
Kanggushu aqueous extract and suet extract for 12 weeks
respectively
while the other 3 groups were administered orally saline. The whole body bone mineral density
bone mineral content
organ coefficient of uterus
serum estradiol and alkaline phosphatase contents
blood calcium
phosphorus
interleukin 6 and bone Gla-protein levels after treatment were monitored. Additionally
three-point bending test of femur
HE staining
and scanning electron microscope were performed to explore the pharmacodynamics and underlying mechanisms. In comparison with ovariectomized rats of model group
Kanggushu aqueous extract high-dose resulted in an increased bone mineral density
bone mineral content and organ coefficient of uterus
improved estradiol level
and improved maximum load and structural stiffness (P<0.05 or P<0.01). Two-dimensional and three-dimensional trabecular structure was also observed under HE staining and scanning electron microscopy
and the number and thickness of trabecular bone in Kanggushu aqueous extract high-dose group was significantly increased compared to the model group
while the lipid droplets in bone marrow cavity were significantly less. However
there were no significant differences in blood calcium
total serum alkaline phosphatase and bone Gla protein among different treatment groups. Overall
the osteoprotective effects of Kanggushu aqueous extract were comparable to those of nilestriol and were significantly more effective than those of Xianling Gubao Capsule. The preventive effects of Kanggushu aqueous extract might be partly due to the increased estradiol level
accelerated restoration of bone trabecular reticulate structure
and accordingly increased bone mineral density in osteoporosis rats.
Riggs BL, Melton LJ 3rd. Involutional osteoporosis. N Engl J Med 1986;314:1676–1686.
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115–137.
Lindsay R. Sex steroids in the pathogenesis and prevention of osteoporosis. In: Riggs BL, ed. Osteoporosis: etiology, diagnosis and management. New York: Raven Press;1988:333–358.
Lewiecki EM. Management of osteoporosis. Clin Mol Allergy 2004;2:9.
Riggs BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17:505–511.
Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011;22:1277–1288.
Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992;2:285–289.
Zhao WY, Dong BR, Ou XM, Zhang YF, Zhou Y. New development and evidence of the treatment of osteoporosis drugs. Chin J Osteoporosis (Chin) 2003;9:80–82.
Zhao YF, Shi YY, Shen PZ, Xu Y, Wang HB. Effects of Xianling Gubao on the bone histomorphometry in ovariectomized rats. J Tradit Chin Orthoped Traumatol (Chin) 2004;12:3–5.
Jiang YL, Huo HR, Li LF, Guo SY. Effects of 15 kinds of traditional Chinese and Western medicines on proliferation and maturation of osteoblasts in rats. Chin J Osteoporosis (Chin) 2008;8:342–345.
Ren GY, Lu L, Zhou N, Zhang GL, Wang JP. Effects of Xianling Gubao Capsule on the growth hormone concentration and transforming growth factor-β expression during fracture healing progress. Guizhou Med (Chin) 2003;27:595–597.
Cui SZ, Hu YL. Effects of Xianling Gubao Capsule on biochemical indicators of bone metabolism in ovariectomized rats. Chin J Clin Med Pract (Chin) 2007;16:260–262.
Zhang Y, Wu CF. Development of Chinese agents Xianling Gubao on the treatment of osteoporosis. Inf Tradit Chin Med (Chin) 2007;24:16–17.
Zhang XZ, Han JF, Qian GF, He M, Li Y, Gu L. Effects of Xianling Gubao on the bone mineral density, IL-6, TNF-a, and IGF-I in PMO. Chin J Osteoporosis (Chin) 2004;10:90–93.
Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991;15:175–191.
Cao WH, Yu LJ. Postmenopausal patients with estrogen. China Med Abstracts Geriatr (Chin) 2000;3:196–198.
Wang Y, Liu CL, Yu XW. Effects of estrogen and estrogen receptor in adipose tissue. Int Med J (Maternal and Child Health, Chin) 2003;14:94–95.
Zhang GA, Liu XM, Shi SL, Chen ZR, Shi YB. The relationship between blood IL-6 and E2 level and compact bone substance density in perimenopausal and postmenopausal women. Shanghai J Immunol (Chin)1999;19:35–37.